Literature DB >> 30762111

Added value of apparent diffusion coefficient in distinguishing between serous and mucin-producing pancreatic cystic neoplasms.

Pallavi Pandey1, Ankur Pandey1, Nannan Shao1, Farnaz Najmi Varzaneh1, Mounes Aliyari Ghasabeh1, Manijeh Zharghampour1, Pegah Khoshpouri1, Daniel Fouladi1, John Eng1, Anne Marie O'Broin-Lennon2, Marcia Canto2, Ralph H Hruban3, Ihab R Kamel4.   

Abstract

OBJECTIVES: To evaluate the added value of diffusion-weighted imaging (DWI) on MRI in differentiating serous from mucin-producing pancreatic cystic neoplasms (PCNs).
METHODS: One hundred seventeen patients with PCN measuring ≥ 10 mm were included. Three readers independently evaluated MRI with and without the use of apparent diffusion coefficient (ADC). Logistic regression was used to analyze whether confidence scores were different with the use of different image sets. Diagnostic performance with and without ADC was compared.
RESULTS: DWI/ADC improved confidence in 44.8%, 73.6%, and 78.2% of patients by the three readers in distinguishing serous from mucin-producing PCNs. The use of ADC increased the probability of a higher confidence in the differentiation as compared to morphological imaging for all three readers (p < 0.001). Odds ratio for increase in the diagnostic confidence with the use of ADC for the three readers with decreasing years of experience were 5.8, 6.8, and 12.7. The diagnostic accuracy of morphological MRI with ADC was higher than that without ADC for two of three readers with lesser experience (87.2% vs. 80.8%; 91.5% vs. 80.8%).
CONCLUSION: DWI may have added value as a complementary tool to conventional morphological MRI in differentiating between serous and mucin-producing PCNs with possibly greater value for readers with less experience in reading abdominal MRI. KEY POINTS: • Optimal management of PCNs requires differentiation of serous from mucin-producing PCNs. • ADC measurements allow increased confidence in differentiating serous from mucin-producing PCNs. • ADC measurements increase the accuracy in diagnosing serous versus mucin-producing PCNs.

Entities:  

Keywords:  Cysts; Diffusion MRI; Magnetic resonance imaging; Mucin; Pancreas

Mesh:

Substances:

Year:  2019        PMID: 30762111     DOI: 10.1007/s00330-019-6010-9

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  32 in total

Review 1.  Diffusion MR imaging: clinical applications.

Authors:  D Le Bihan; R Turner; P Douek; N Patronas
Journal:  AJR Am J Roentgenol       Date:  1992-09       Impact factor: 3.959

2.  Incidental pancreatic cysts: do we really know what we are watching?

Authors:  Camilo Correa-Gallego; Cristina R Ferrone; Sarah P Thayer; Jennifer A Wargo; Andrew L Warshaw; Carlos Fernández-Del Castillo
Journal:  Pancreatology       Date:  2010-05-17       Impact factor: 3.996

3.  Variability in absolute apparent diffusion coefficient values across different platforms may be substantial: a multivendor, multi-institutional comparison study.

Authors:  Makoto Sasaki; Kei Yamada; Yoshiyuki Watanabe; Mieko Matsui; Masahiro Ida; Shunrou Fujiwara; Eri Shibata
Journal:  Radiology       Date:  2008-11       Impact factor: 11.105

4.  High prevalence of pancreatic cysts detected by screening magnetic resonance imaging examinations.

Authors:  Koen de Jong; C Yung Nio; John J Hermans; Marcel G Dijkgraaf; Dirk J Gouma; Casper H J van Eijck; Eddy van Heel; Gunter Klass; Paul Fockens; Marco J Bruno
Journal:  Clin Gastroenterol Hepatol       Date:  2010-06-01       Impact factor: 11.382

5.  Measurement of the apparent diffusion coefficient in intraductal mucin-producing tumor of the pancreas by diffusion-weighted echo-planar MR imaging.

Authors:  H Irie; H Honda; T Kuroiwa; K Yoshimitsu; H Aibe; K Shinozaki; K Masuda
Journal:  Abdom Imaging       Date:  2002 Jan-Feb

6.  Characterization of cystic pancreatic masses: relative accuracy of CT and MRI.

Authors:  Brendan C Visser; Benjamin M Yeh; Aliya Qayyum; Lawrence W Way; Charles E McCulloch; Fergus V Coakley
Journal:  AJR Am J Roentgenol       Date:  2007-09       Impact factor: 3.959

7.  CT imaging spectrum of pancreatic serous tumors: based on new pathologic classification.

Authors:  Hye Young Sun; Se Hyung Kim; Min A Kim; Jae Young Lee; Joon Koo Han; Byung Ihn Choi
Journal:  Eur J Radiol       Date:  2010-01-06       Impact factor: 3.528

8.  Evaluation of optimized inversion-recovery fat-suppression techniques for T2-weighted abdominal MR imaging.

Authors:  Thomas C Lauenstein; Puneet Sharma; Timothy Hughes; Keith Heberlein; Dana Tudorascu; Diego R Martin
Journal:  J Magn Reson Imaging       Date:  2008-06       Impact factor: 4.813

9.  Differentiation of intraductal papillary mucinous neoplasms from other pancreatic cystic masses: comparison of multirow-detector CT and MR imaging using ROC analysis.

Authors:  Su Jin Song; Jeong Min Lee; Young Jun Kim; Se Hyung Kim; Jae Young Lee; Joon Koo Han; Byung Ihn Choi
Journal:  J Magn Reson Imaging       Date:  2007-07       Impact factor: 4.813

10.  Typical and atypical manifestations of serous cystadenoma of the pancreas: imaging findings with pathologic correlation.

Authors:  Jin-Young Choi; Myeong-Jin Kim; Jae Young Lee; Joon Seok Lim; Jae Joon Chung; Ki Whang Kim; Hyung Sik Yoo
Journal:  AJR Am J Roentgenol       Date:  2009-07       Impact factor: 3.959

View more
  2 in total

Review 1.  Accuracy of quantitative diffusion-weighted imaging for differentiating benign and malignant pancreatic lesions: a systematic review and meta-analysis.

Authors:  LuShun Zhang; LongLin Yin; MeiLin Zhu; ChuanDe Zhang; JingXin Yan; Ju Sun; XinYi Zhao
Journal:  Eur Radiol       Date:  2021-04-13       Impact factor: 5.315

2.  Diagnostic Performance of Diffusion-Weighted Imaging for Differentiating Malignant From Benign Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Systematic Review and Meta-Analysis.

Authors:  Fan Xu; Yingying Liang; Wei Guo; Zhiping Liang; Liqi Li; Yuchao Xiong; Guoxi Ye; Xuwen Zeng
Journal:  Front Oncol       Date:  2021-07-05       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.